UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on Varian Medical Systems


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


In a report published Friday, Jefferies & Company reiterated its Buy rating on Varian Medical Systems (NYSE: VAR), and raised its price target from $65.00 to $68.00.Jefferies noted, “VAR posted a strong F4Q with beats in revenues, EPS, and orders. Initial F13 guidance calls for 8-9% top-line growth. The strong surge in orders and higher outlook should ease persistent concerns of pressures from potential CMS reimbursement cuts, pricing, and competition.”Varian Medical Systems closed on Thursday at $58.10.

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorPrice TargetAnalyst RatingsJefferies & Company